Next Article in Journal
Fee-for-Service Cancer Rehabilitation Programs Improve Health-Related Quality of Life
Previous Article in Journal
Will Oncologists Applaud the Paris Accord? Time to Rethink Global Mega-Conferences
 
 
Current Oncology is published by MDPI from Volume 28 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Multimed Inc..
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Cancer Incidence, Mortality, and Stage at Diagnosis in First Nations Living in Manitoba

1
Department of Community Health Sciences, University of Manitoba, Winnipeg, MB, Canada
2
Epidemiology and Cancer Registry, CancerCare Manitoba, Winnipeg, MB, Canada
3
Cancer Control Research, BC Cancer Agency, Vancouver, BC, Canada
4
Screening Programs, CancerCare Manitoba, Winnipeg, MB, Canada
*
Author to whom correspondence should be addressed.
Curr. Oncol. 2016, 23(4), 225-232; https://0-doi-org.brum.beds.ac.uk/10.3747/co.23.2906
Submission received: 5 May 2016 / Revised: 3 June 2016 / Accepted: 9 July 2016 / Published: 1 August 2016

Abstract

Background: In the present study, we examined breast (BCa) and colorectal cancer (CRC) incidence and mortality and stage at diagnosis for First Nations (FN) individuals and all other Manitobans (AOMS). Methods: Several population-based databases were linked to determine ethnicity and to calculate age-standardized incidence and mortality rates. Logistic regression was used to compare BCa and CRC stage at diagnosis. Results: From 1984–1988 to 2004–2008, the incidence of BCa increased for FN and aom women. Breast cancer mortality increased for fn women and decreased for AOM women. First Nations women were significantly more likely than aom women to be diagnosed at stages IIIIV than at stage I [odds ratio (OR) for women ≤50 years of age: 3.11; 95% confidence limits (CL): 1.20, 8.06; OR for women 50–69 years of age: 1.72; 95% CL: 1.03, 2.88). The incidence and mortality of CRC increased for FN individuals, but decreased for AOMS. First Nations status was not significantly associated with CRC stage at diagnosis (OR for stages III compared with stages IIIIV: 0.98; 95% CL: 0.68, 1.41; OR for stages IIII compared with stage IV: 0.91; 95% CL: 0.59, 1.40). Conclusions: Our results underscore the need for improved cancer screening participation and targeted initiatives that emphasis collaboration with fn communities to reduce barriers to screening and to promote healthy lifestyles.
Keywords: Colorectal cancer; breast cancer; indigenous health Colorectal cancer; breast cancer; indigenous health

Share and Cite

MDPI and ACS Style

Decker, K.M.; Kliewer, E.V.; Demers, A.A.; Fradette, K.; Biswanger, N.; Musto, G.; Elias, B.; Turner, D. Cancer Incidence, Mortality, and Stage at Diagnosis in First Nations Living in Manitoba. Curr. Oncol. 2016, 23, 225-232. https://0-doi-org.brum.beds.ac.uk/10.3747/co.23.2906

AMA Style

Decker KM, Kliewer EV, Demers AA, Fradette K, Biswanger N, Musto G, Elias B, Turner D. Cancer Incidence, Mortality, and Stage at Diagnosis in First Nations Living in Manitoba. Current Oncology. 2016; 23(4):225-232. https://0-doi-org.brum.beds.ac.uk/10.3747/co.23.2906

Chicago/Turabian Style

Decker, K.M., E.V. Kliewer, A.A. Demers, K. Fradette, N. Biswanger, G. Musto, B. Elias, and D. Turner. 2016. "Cancer Incidence, Mortality, and Stage at Diagnosis in First Nations Living in Manitoba" Current Oncology 23, no. 4: 225-232. https://0-doi-org.brum.beds.ac.uk/10.3747/co.23.2906

Article Metrics

Back to TopTop